Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00083941
Status:
COMPLETED
Last Update Posted:
2020-10-19
First Post:
2004-06-03
Brief Title:
A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer
Sponsor:
Oxford BioMedica
Organization:
Oxford BioMedica
Organization Data
Organization:
Oxford BioMedica
Class:
INDUSTRY
Study ID:
TV2 Renal
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oxford BioMedica
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ORION Clinical Services | INDUSTRY |
| Columbia University | OTHER |